Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stojkovic

Showing results (1001-1010 of 1,067) with videos related to

Pageof 107
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|April 4, 2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathyHarmen Reyngoudt, Fiona E Smith, Ericky Caldas de Almeida Araújo, et al.
Neuromuscular Disorders : NMD|February 21, 2021
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same diseaseUrsula Moore, Heather Gordish, Jordi Diaz-Manera, et al.
European Journal of Neurology|February 13, 2025
Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13Alessandro Bertini, Mary M Reilly, Chiara Pisciotta, et al.
Orphanet Journal of Rare Diseases|December 19, 2014
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1AShahram Attarian, Jean-Michel Vallat, Laurent Magy, et al.
Journal of Neurology|September 24, 2021
Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohortSusana Quijano-Roy, Jana Haberlova, Claudia Castiglioni, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathyUrsula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 24, 2025
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE studyAriadna Ortiz-Brugués, Davide Fattore, Marie Boileau, et al.
Annals of Neurology|May 14, 2020
GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency SyndromeA Reghan Foley, Yaqun Zou, James E Dunford, et al.
Orphanet Journal of Rare Diseases|September 2, 2025
Prevalence and predictors of uncommon features in FSHD1 patients: insights from the French FSHD registryBenoît Sanson, Abderhmane Slioui, Jérémy Garcia, et al.
Journal of Neuromuscular Diseases|March 22, 2021
Clinical and Molecular Spectrum Associated with COL6A3 c.7447A>G p.(Lys2483Glu) Variant: Elucidating its Role in Collagen VI-related MyopathiesRocío N Villar-Quiles, Sandra Donkervoort, Alix de Becdelièvre, et al.
Pageof 107

Showing results (1001-1010 of 1,067) with videos related to

Sort By:
Pageof 107
Journal of Cachexia, Sarcopenia and Muscle|April 4, 2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathyHarmen Reyngoudt, Fiona E Smith, Ericky Caldas de Almeida Araújo, et al.
Neuromuscular Disorders : NMD|February 21, 2021
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same diseaseUrsula Moore, Heather Gordish, Jordi Diaz-Manera, et al.
European Journal of Neurology|February 13, 2025
Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13Alessandro Bertini, Mary M Reilly, Chiara Pisciotta, et al.
Orphanet Journal of Rare Diseases|December 19, 2014
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1AShahram Attarian, Jean-Michel Vallat, Laurent Magy, et al.
Journal of Neurology|September 24, 2021
Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohortSusana Quijano-Roy, Jana Haberlova, Claudia Castiglioni, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathyUrsula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 24, 2025
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE studyAriadna Ortiz-Brugués, Davide Fattore, Marie Boileau, et al.
Annals of Neurology|May 14, 2020
GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency SyndromeA Reghan Foley, Yaqun Zou, James E Dunford, et al.
Orphanet Journal of Rare Diseases|September 2, 2025
Prevalence and predictors of uncommon features in FSHD1 patients: insights from the French FSHD registryBenoît Sanson, Abderhmane Slioui, Jérémy Garcia, et al.
Journal of Neuromuscular Diseases|March 22, 2021
Clinical and Molecular Spectrum Associated with COL6A3 c.7447A>G p.(Lys2483Glu) Variant: Elucidating its Role in Collagen VI-related MyopathiesRocío N Villar-Quiles, Sandra Donkervoort, Alix de Becdelièvre, et al.
Pageof 107